Serum Lipoprotein (a) as a Diagnostic Marker of Coronary Artery Disease: A Case-Control Study

Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 7

Abstract

Introduction: Coronary Artery Disease (CAD) is a major cause of mortality in India. Conventional risk factors fail to explain the increasing burden of CAD, thus necessitating to search for newer risk factors like Lipoprotein (a) {Lp(a)}. Lp(a) is considered as one of the risk marker of CAD. Lp(a) levels have shown wide ethnic variation among human population. Aim: The study was aimed to estimate Lp(a) levels in CAD patients and to compare it with healthy controls. To see the correlation between Lp (a) with other lipid parameters and also to find the best cut-off value for Lp(a) in CAD patients in North Karnataka population. Materials and Methods: This was hospital based, observational, case-control study done on 120 participants, with 60 CAD patients and 60 healthy controls. Lipid profile, Lp(a) and FBS (Fasting Blood Sugar) was analysed along with anthropometric measurements. Quantitative data expressed as mean±SD. Student's t-test for comparison, Pearson correlation for correlation and Receiver Operating Curve (ROC) to get the best cut-off value for Lp(a) was used. Results: Lp(a) levels were significantly increased (p<0.001) in CAD patients compared to controls with mean values 52.34±24.87 and 16.81±3.91 respectively. Triglyceride (TG) was significantly increased (p<0.001) and High Density Lipoprotein (HDL) was significantly decreased in CAD patients. Area under the curve is >0.8 with 78% sensitivity and 86% specificity. The best cut-off value is 23.7 mg/dL. Lp(a) positively correlated with Total Cholesterol (TC), Low Density Lipoprotein cholesterol (LDL) and negatively correlated with HDL. Conclusion: Raised Lp(a) levels is associated with an increased risk and may serve as marker of CAD. When Lp(a) is above 23.7 mg/dL. it acts as a predictor for CAD even when lipid levels are in normal range. It is better to assess the Lp(a) along with routine lipid profile in all patients with CAD in north Karnataka.

Authors and Affiliations

M. M. Kavitha, Jeevan G. Ambekar, Sangappa V. Kashinakunti, Nilima Dongre

Keywords

Related Articles

Thoracic Sarcoidosis: Imaging with High Resolution Computed Tomography

Introduction: Sarcoidosis is a disease of unknown aetiology that primarily affects the lungs. Clinical and radiological findings with demonstration of non caseating granulomas on pathology is utilised for diagnosing the...

Evaluation of Greater Sciatic Notch Parameters in Sex Determination of Hip Bone by Three-Dimensional CT Images

ABSTRACT Introduction: Sex determination of an anonymous individual is one of the main objective when human skeletal remains are found, both in forensic investigation and archaeological studies. Aim: To evaluate the role...

Pre-analytical Errors at the Chemical Pathology Laboratory of a Teaching Hospital

Introduction: The Chemical Pathology Laboratory at the University Hospital of the West Indies (UHWI) processes specimens received from inpatients, the outpatient department and other medical facilities in Jamaica. Specif...

Comparison of Intraoperative and Postoperative Morbidity between Carbondioxide Laser Tonsillectomy and Dissection Tonsillectomy: A Randomised Clinical Trial

ABSTRACT Introduction: Tonsillectomy is one of the most common procedures done in Ear, Nose and Throat department. Various methods of tonsillectomy have come into practice starting from dissection and snare to the recent...

Download PDF file
  • EP ID EP522345
  • DOI 10.7860/JCDR/2018/36832.11774
  • Views 69
  • Downloads 0

How To Cite

M. M. Kavitha, Jeevan G. Ambekar, Sangappa V. Kashinakunti, Nilima Dongre (2018). Serum Lipoprotein (a) as a Diagnostic Marker of Coronary Artery Disease: A Case-Control Study. Journal of Clinical and Diagnostic Research, 12(7), 10-13. https://europub.co.uk/articles/-A-522345